Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.565 USD | +0.98% |
|
-0.19% | +11.04% |
26/06 | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
26/06 | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.04% | 103M | |
+18.08% | 44.44B | |
+41.98% | 40.03B | |
-10.56% | 37.68B | |
+30.45% | 31.46B | |
-7.79% | 27.29B | |
+13.58% | 26.29B | |
+42.18% | 13.8B | |
+30.06% | 12.46B | |
-7.44% | 11.26B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019